rxstatShortages › Tadalafil

Tadalafil (Adcirca) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 15, 2026

Some Tadalafil products are in shortage in Canada (2 of 45 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.

A medication used to treat erectile dysfunction and symptoms of an enlarged prostate.

Products affected
2 / 45
In shortage since
Nov 30, 2017
Est. full return
Aug 14, 2026
Reports on file
148
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TARO-TADALAFIL
20MG · TABLET · SUN PHARMA CANADA INC
DIN 02452111 · since Apr 16, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
MAR-TADALAFIL
2.5MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02452286 · since Nov 30, 2017, no end estimate · Delay in shipping of the drug.
Anticipated
TADALAFIL
20MG · TABLET · SANIS HEALTH INC
DIN 02457032 · Disruption of the manufacture of the drug.
Anticipated
TADALAFIL
5MG · TABLET · SANIS HEALTH INC
DIN 02457016 · Disruption of the manufacture of the drug.
Discontinued
ADCIRCA
20MG · TABLET · ELI LILLY CANADA INC
DIN 02338327
Resolved
MYLAN-TADALAFIL
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410656 · ended Feb 6, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TADALAFIL
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02452073 · ended Jan 14, 2026 · Released Jan 14, 2026. Short-dated inventory has been pulled
Resolved
MYLAN-TADALAFIL
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410664 · ended Oct 2, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-TADALAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410648 · ended Sep 29, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-TADALAFIL
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410656 · ended Sep 29, 2025 · Disruption of the manufacture of the drug.
Resolved
TADALAFIL
10MG · TABLET · SANIS HEALTH INC
DIN 02457024 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
Resolved
TADALAFIL
5MG · TABLET · SANIS HEALTH INC
DIN 02457016 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Tadalafil is currently affected by 2 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, MARCAN PHARMACEUTICALS INC.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Tadalafil is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BE).

Recent changes

Common questions

What is Tadalafil used for?

A medication used to treat erectile dysfunction and symptoms of an enlarged prostate.

When will Tadalafil be back in stock in Canada?

The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Tadalafil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other urologicals, incl antispasmodics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.